tiprankstipranks
Trending News
More News >
MedCap AB (DE:61MA)
FRANKFURT:61MA
Germany Market
Advertisement

MedCap AB (61MA) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
MedCap AB’s (61MA) Moving Averages Convergence Divergence (MACD) indicator is 2.55, suggesting MedCap AB is a Buy.
MedCap AB’s (61MA) 20-Day exponential moving average is 56.67, while MedCap AB’s (61MA) share price is €58.2, making it a Buy.
MedCap AB’s (61MA) 50-Day exponential moving average is 51.13, while MedCap AB’s (61MA) share price is €58.2, making it a Buy.

MedCap AB (61MA) Pivot Points

Aug 23, 2025, 03:28 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
57.60
57.60
57.60
57.60
57.60
57.60
57.60
Fibonacci
57.60
57.60
57.60
57.60
57.60
57.60
57.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MedCap AB (61MA) Moving Averages

Aug 23, 2025, 03:28 PM
Period
Simple
Exponential
MA5
58.16Buy
58.23Sell
MA10
58.55Sell
58.18Buy
MA20
58.36Sell
56.67Buy
MA50
48.83Buy
51.13Buy
MA100
43.15Buy
46.38Buy
MA200
42.27Buy
44.67Buy
MedCap AB’s (61MA) 10-Day exponential moving average is 58.18, while MedCap AB’s (61MA) share price is €58.2, making it a Buy.
MedCap AB’s (61MA) 100-Day exponential moving average is 46.38, while MedCap AB’s (61MA) share price is €58.2, making it a Buy.
MedCap AB’s (61MA) stock price is €58.2 and MedCap AB’s (61MA) 50-day simple moving average is 48.83, creating a Buy signal.
MedCap AB’s (61MA) stock price is €58.2 and MedCap AB’s (61MA) 100-day simple moving average is 43.15, creating a Buy signal.
MedCap AB’s (61MA) stock price is €58.2 and MedCap AB’s (61MA) 200-day simple moving average is 42.27, creating a Buy signal.

MedCap AB (61MA) Technical Indicators

Aug 23, 2025, 03:28 PM
Name
Value
Implied Action
RSI (14)
62.19
Neutral
STOCH (9,6)
31.11
Neutral
STOCHRSI (14)
26.67
Neutral
MACD (12,26)
2.55
Buy
ADX (14)
41.61
Neutral
Williams %R
-70.00
Buy
CCI (14)
-14.17
Neutral
ATR (14)
0.94
-
Ultimate Oscillator
46.87
Neutral
ROC
0.34
Buy
MedCap AB’s (61MA) Relative Strength Index (RSI) is 62.19, creating a Neutral signal.
MedCap AB’s (61MA) Trend Strength Indicator (ADX) is 41.61, creating a Neutral signal.
MedCap AB’s (61MA) Commodity Channel Index (CCI) is -14.17, creating a Neutral signal.
MedCap AB’s (61MA) Price Rate of Change (ROC) is 0.34, creating a Buy signal.

FAQ

Is 61MA a Buy, Hold, or Sell?
Based on 61MA’s technical indicators, 61MA is a Buy.
    What is 61MA’s RSI (14)?
    61MA’s RSI (14) is 62.19, which suggests 61MA is a Neutral.
      What is 61MA’s MACD?
      61MA’s MACD is 2.55, which suggests 61MA is a Buy.
        What is 61MA’s 5-day moving average?
        61MA’s 5-day moving average is 58.16, which suggests 61MA is a Buy.
          What is 61MA’s 20-day moving average?
          61MA 20-day moving average is 58.35, which suggests 61MA is a Sell.
            What is 61MA’s 50-day moving average?
            61MA’s 50-day moving average is 48.83, which suggests 61MA is a Buy.
              What is 61MA’s 200-day moving average?
              61MA’s 200-day moving average is 42.27, which suggests 61MA is a Buy.
                What is 61MA’s Williams % R (14)?
                61MA’s Williams % R (14) is -70.00, which suggests 61MA is a Buy.
                  What is 61MA’s CCI (14)?
                  61MA’s CCI (14) is -14.17, which suggests 61MA is a Neutral.
                    What is the share price of MedCap AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis